Instituto Dante Pazzanese de Cardiologia, São Paulo, SP, Brazil.
Federal University of São Paulo, São Paulo, SP, Brazil.
High Blood Press Cardiovasc Prev. 2024 Nov;31(6):687-694. doi: 10.1007/s40292-024-00685-7. Epub 2024 Nov 18.
The long-term efficacy of renal denervation (RDN) has not been extensively documented.
To describe the long-term follow-up of patients after RDN.
We evaluated patients with resistant hypertension (RH) who underwent RDN with irrigated catheter from 2012 to 2014 at a single centre. Office blood pressure (BP) and 24-hour ambulatory BP were assessed. Clinical event (stroke, myocardial infarction, need for dialysis, or death from any cause), left ventricular mass index (LVMI), estimated glomerular filtration rate (eGFR), and urine albumin-to-creatinine ratio (uACR) were evaluated.
The analysis included 20 individuals (age 51 ± 10 years, 75% female, ambulatory systolic BP [SBP] 168 ± 22 mmHg, ambulatory diastolic BP [DBP] 101 ± 19 mmHg, taking 7 [IQR: 6-8] antihypertensive medications). The median follow-up period was 8.5 (IQR: 5.6-9.4) years. Mean (± SD) changes from baseline were: -47 ± 41 mmHg for office SBP, -25 ± 20 mmHg for office DBP, -29 ± 26 mmHg for ambulatory SBP, and -15 ± 16 mmHg for ambulatory DBP. The number of antihypertensive drugs markedly decreased one month after RDN and a gradual upward trend was observed over time. A clinical event occurred in 9 (45%) participants. LVMI decreased from 152 ± 37 to 120 ± 31 g/m (p = 0.015), the eGFR declined from 88.9 ± 15.6 to 73.1 ± 24.2 mL/min/1.73 m (p = 0.034), and the uACR did not significantly change from baseline to follow-up.
In this observational study of patients with uncontrolled RH, RDN with an irrigated catheter was associated with a sustained BP reduction for up to a decade. However, a potential waning efficacy was suggested by the increasing use of antihypertensive medications over time.
肾去神经术(RDN)的长期疗效尚未得到广泛证实。
描述 RDN 后患者的长期随访结果。
我们评估了 2012 年至 2014 年在单中心接受灌流导管 RDN 的难治性高血压(RH)患者。评估诊室血压(BP)和 24 小时动态血压。评估临床事件(中风、心肌梗死、需要透析或任何原因导致的死亡)、左心室质量指数(LVMI)、估算肾小球滤过率(eGFR)和尿白蛋白与肌酐比值(uACR)。
该分析纳入了 20 名患者(年龄 51±10 岁,75%为女性,动态收缩压[SBP]168±22mmHg,动态舒张压[DBP]101±19mmHg,服用 7[IQR:6-8]种降压药物)。中位随访时间为 8.5(IQR:5.6-9.4)年。与基线相比,平均(±SD)变化为:诊室 SBP 降低 47±41mmHg,诊室 DBP 降低 25±20mmHg,动态 SBP 降低 29±26mmHg,动态 DBP 降低 15±16mmHg。RDN 后一个月抗高血压药物的数量显著减少,且随时间呈逐渐上升趋势。9 名(45%)参与者发生临床事件。LVMI 从 152±37g/m 降至 120±31g/m(p=0.015),eGFR 从 88.9±15.6mL/min/1.73m 降至 73.1±24.2mL/min/1.73m(p=0.034),uACR 从基线到随访无显著变化。
在这项对未控制的 RH 患者的观察性研究中,灌流导管 RDN 可维持长达十年的血压降低。然而,随着时间的推移,抗高血压药物的使用逐渐增加,这表明疗效可能逐渐减弱。